Your browser doesn't support javascript.
loading
Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma.
Zhao, Lina; Jiang, Liping; Liu, Yunhe; Wang, Xuebing; Song, Jinge; Sun, Yulin; Bai, Yinlei; Dong, Xiu; Sun, Liying; Wu, Jianxiong; Jiao, Yuchen; Zhao, Xiaohang.
Afiliação
  • Zhao L; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Jiang L; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Liu Y; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wang X; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Song J; Liver Transplantation Center, National Clinical Research Center for Digestive Diseases (NCRC-DD), Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Sun Y; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Bai Y; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Dong X; Jinchenjunchuang Clinical Laboratory, Hangzhou, China.
  • Sun L; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Wu J; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Jiao Y; Liver Transplantation Center, National Clinical Research Center for Digestive Diseases (NCRC-DD), Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Zhao X; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Clin Transl Med ; 12(4): e793, 2022 04.
Article em En | MEDLINE | ID: mdl-35384341
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / DNA Tumoral Circulante / Neoplasias Hepáticas / Células Neoplásicas Circulantes Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Clin Transl Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / DNA Tumoral Circulante / Neoplasias Hepáticas / Células Neoplásicas Circulantes Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Clin Transl Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China